The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Acidex Oral Suspension, Sodium Alginate 500mg, Sodium Bicarbonate 267mg, Calcium Carbonate 160mg/10ml



Pinewood Laboratories LtdPA0281/075/001

Main Information

Trade NameAcidex Oral Suspension, Sodium Alginate 500mg, Sodium Bicarbonate 267mg, Calcium Carbonate 160mg/10ml
Active SubstancesSodium alginate
Sodium bicarbonate
Calcium carbonate
Dosage FormOral suspension
Licence HolderPinewood Laboratories Ltd
Licence NumberPA0281/075/001

Group Information

ATC CodeB05CB Salt solutions
B05CB04 sodium bicarbonate

Status

License statusAuthorised
Licence Issued26/06/1998
Legal statusProduct not subject to medical prescription
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to the general public
Conditions of Licence
Marketing StatusMarketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back